UK markets close in 8 hours 14 minutes
  • FTSE 100

    6,728.53
    +15.58 (+0.23%)
     
  • FTSE 250

    20,713.66
    +110.77 (+0.54%)
     
  • AIM

    1,179.95
    -1.18 (-0.10%)
     
  • GBP/EUR

    1.1250
    +0.0013 (+0.11%)
     
  • GBP/USD

    1.3661
    +0.0027 (+0.20%)
     
  • BTC-GBP

    26,050.86
    -256.37 (-0.97%)
     
  • CMC Crypto 200

    705.42
    -9.77 (-1.37%)
     
  • S&P 500

    3,798.91
    +30.66 (+0.81%)
     
  • DOW

    30,930.52
    +116.26 (+0.38%)
     
  • CRUDE OIL

    53.39
    +0.41 (+0.77%)
     
  • GOLD FUTURES

    1,854.80
    +14.60 (+0.79%)
     
  • NIKKEI 225

    28,523.26
    -110.20 (-0.38%)
     
  • HANG SENG

    29,950.98
    +308.70 (+1.04%)
     
  • DAX

    13,815.06
    -33.29 (-0.24%)
     
  • CAC 40

    5,615.38
    +16.77 (+0.30%)
     

Global Monoclonal Antibodies Market Value to Increase by Almost $ 55 Billion During 2020-2024 | Advent of Low-priced Biosimilar Monoclonal Antibodies to Foster Growth | Technavio

·4-min read

The monoclonal antibodies market is poised to grow by USD 54.55 billion during 2020-2024, progressing at a CAGR of over 7% during the forecast period.

This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20201204005045/en/

Technavio has announced its latest market research report titled Global Monoclonal Antibodies Market 2020-2024 (Graphic: Business Wire)

For a More Detailed Analysis, Get a Free Sample Report Delivered Instantly

The report on the monoclonal antibodies market provides a holistic update, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis.

The report offers an up-to-date analysis regarding the current global market scenario and the overall market environment. The market is driven by the advent of low-priced biosimilar monoclonal antibodies.

The monoclonal antibodies market analysis includes the application, type, and geography landscape. This study identifies the strong R&D pipeline as one of the prime reasons driving the monoclonal antibodies market growth during the next few years.

This report presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters.

The monoclonal antibodies market covers the following areas:

Monoclonal Antibodies Market Sizing
Monoclonal Antibodies Market Forecast
Monoclonal Antibodies Market Analysis

Develop Smart Strategies for Your Business: Get a Free Sample Report Now!

Companies Mentioned

  • AbbVie Inc.

  • AstraZeneca Plc

  • Bristol-Myers Squibb Co.

  • F. Hoffmann-La Roche Ltd.

  • GlaxoSmithKline Plc

  • Johnson & Johnson

  • Merck & Co. Inc.

  • Novartis AG

  • Pfizer Inc.

  • Sanofi

Related Reports on Health Care Include:

Global Cancer Monoclonal Antibodies Market - Global cancer monoclonal antibodies market is segmented by type (naked monoclonal antibodies and conjugated and bi-specific monoclonal antibodies), MoA (immune system suppressors, kill or inhibit malignant cells, angiogenesis inhibitors, radiation therapy to cancer cells, and radiation chemotherapy to cancer cells), and geography (Asia, Europe, North America, and ROW). Click Here to Get an Exclusive Free Sample Report

Global Biosimilar Monoclonal Antibodies (mAbs) Market - Global biosimilar monoclonal antibodies market is segmented by application (cancer and non-cancer) and geography (Asia, Europe, North America, and ROW). Click Here to Get an Exclusive Free Sample Report

Key Topics Covered:

Executive Summary

Market Landscape

  • Market ecosystem

  • Market characteristics

  • Value chain analysis

Market Sizing

  • Market definition

  • Market segment analysis

  • Market size 2019

  • Market outlook: Forecast for 2019 - 2024

Five Forces Analysis

  • Five forces summary

  • Bargaining power of buyers

  • Bargaining power of suppliers

  • Threat of new entrants

  • Threat of substitutes

  • Threat of rivalry

  • Market condition

Market Segmentation by Application

  • Market segments

  • Comparison by Application

  • Oncology - Market size and forecast 2019-2024

  • Autoimmune disorders - Market size and forecast 2019-2024

  • Infectious diseases - Market size and forecast 2019-2024

  • Other applications - Market size and forecast 2019-2024

  • Market opportunity by Application

Market Segmentation by Type

  • Segmentation by type of monoclonal antibodies

Customer Landscape

Geographic Landscape

  • Geographic segmentation

  • Geographic comparison

  • North America - Market size and forecast 2019-2024

  • Europe - Market size and forecast 2019-2024

  • Asia - Market size and forecast 2019-2024

  • ROW - Market size and forecast 2019-2024

  • Key leading countries

  • Market opportunity by geography

  • Market drivers

  • Market challenges

  • Market trends

Vendor Landscape

  • Competitive Scenario

  • Vendor Landscape

  • Landscape disruption

Vendor Analysis

  • Vendors covered

  • Market positioning of vendors

  • AbbVie Inc.

  • AstraZeneca Plc

  • Bristol-Myers Squibb Co.

  • F. Hoffmann-La Roche Ltd.

  • GlaxoSmithKline Plc

  • Johnson & Johnson

  • Merck & Co. Inc.

  • Novartis AG

  • Pfizer Inc.

  • Sanofi

Appendix

  • Scope of the report

  • Currency conversion rates for US$

  • Research methodology

  • List of abbreviations

Technavio suggests three forecast scenarios (optimistic, probable, and pessimistic) considering the impact of COVID-19. Technavio’s in-depth research has direct and indirect COVID-19 impacted market research reports.

Subscribe to World-Class Market Intelligence and gain instant access to 17,000+ market research reports and connect with expert analysts

About Us

Technavio is a leading global technology research and advisory company. Their research and analysis focuses on emerging market trends and provides actionable insights to help businesses identify market opportunities and develop effective strategies to optimize their market positions. With over 500 specialized analysts, Technavio’s report library consists of more than 17,000 reports and counting, covering 800 technologies, spanning across 50 countries. Their client base consists of enterprises of all sizes, including more than 100 Fortune 500 companies. This growing client base relies on Technavio’s comprehensive coverage, extensive research, and actionable market insights to identify opportunities in existing and potential markets and assess their competitive positions within changing market scenarios.

View source version on businesswire.com: https://www.businesswire.com/news/home/20201204005045/en/

Contacts

Technavio Research
Jesse Maida
Media & Marketing Executive
US: +1 844 364 1100
UK: +44 203 893 3200
Email: media@technavio.com
Website: www.technavio.com/